Related Experiment Video
Updated: Feb 15, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers
H Courtney Hodges1, Benjamin Z Stanton2,3,4, Katerina Cermakova1,5
1Department of Molecular & Cellular Biology, Center for Precision Environmental Health, and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Abstract:
Mutation of SMARCA4 (BRG1), the ATPase of BAF (mSWI/SNF) and PBAF complexes, contributes to a range of malignancies and neurologic disorders. Unfortunately, the effects of SMARCA4 missense mutations have remained uncertain. Here we show that SMARCA4 cancer missense mutations target conserved ATPase surfaces and disrupt the mechanochemical cycle of remodeling. We find that heterozygous expression of mutants alters the open chromatin landscape at thousands of sites across the genome. Loss of DNA accessibility does not directly overlap with Polycomb accumulation, but is enriched in 'A compartments' at active enhancers, which lose H3K27ac but not H3K4me1. Affected positions include hundreds of sites identified as superenhancers in many tissues. Dominant-negative mutation induces pro-oncogenic expression changes, including increased expression of Myc and its target genes. Together, our data suggest that disruption of enhancer accessibility represents a key source of altered function in disorders with SMARCA4 mutations in a wide variety of tissues.
Insights
SMARCA4 (BRG1) mutations disrupt DNA accessibility and enhancer function, leading to cancer-promoting gene expression changes. These findings clarify the role of SMARCA4 missense mutations in various diseases.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Biology
Background:
- SMARCA4 (BRG1) mutations are linked to cancers and neurological disorders.
- The impact of SMARCA4 missense mutations on cellular function remains unclear.
Purpose of the Study:
- To investigate the functional consequences of SMARCA4 cancer missense mutations.
- To elucidate the molecular mechanisms by which these mutations contribute to disease.
Main Methods:
- Analysis of SMARCA4 cancer missense mutations targeting ATPase surfaces.
- Assessment of chromatin accessibility landscape alterations.
- Evaluation of gene expression changes, including Myc and its targets.
Main Results:
- SMARCA4 mutations disrupt the ATPase activity and mechanochemical cycle of BAF/PBAF complexes.
- Heterozygous expression of mutants alters chromatin accessibility genome-wide, particularly at active enhancers.
- Mutations lead to pro-oncogenic expression changes, including increased Myc activity.
Conclusions:
- Disruption of enhancer accessibility by SMARCA4 mutations is a key pathogenic mechanism.
- These findings provide insights into SMARCA4-associated malignancies and neurologic disorders.
- Understanding these mechanisms can inform therapeutic strategies for SMARCA4-related diseases.
Related Concept Videos
Incomplete Dominance
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain...
Self-Evaluation: Self-Enhancement and Self-Verification
Negative Regulator Molecules
Positive, Negative, and Zero Work

